Trials / Recruiting
RecruitingNCT06925581
A Trial of HRS-6768 in Patients With Advanced Solid Tumors
A Phase I/II Clinical Trial to Evaluate the Pharmacokinetics, Radiation Dosimetry, Safety and Preliminary Efficacy of HRS-6768 in the Treatment of Patients With Advanced Solid Tumors
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 84 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the pharmacokinetics, radiation dosimetry, safety and preliminary efficacy of HRS-6768. To explore the reasonable dosage of HRS-6768 in the treatment of patients with advanced solid tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-6768 | HRS-6768 |
Timeline
- Start date
- 2025-04-24
- Primary completion
- 2026-04-01
- Completion
- 2027-04-01
- First posted
- 2025-04-13
- Last updated
- 2025-12-03
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06925581. Inclusion in this directory is not an endorsement.